Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.23
At close: May 20 EDT
$10.74
0.514.99%
Pre-Market: 6:47 PM EDT
Comments
Loading...
Cartesian Therapeutics Stock Price, Quotes and Forecasts
RNACNASDAQ
Cartesian Therapeutics (RNAC) Forecast
NewsEarningsCartesian Therapeutics (RNAC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Cartesian Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RNAC | Benzinga
Explore Cartesian Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RNAC.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cartesian Therapeutics (RNAC) stock?
You can purchase shares of Cartesian Therapeutics (NASDAQ:RNAC) through any online brokerage.
Who are Cartesian Therapeutics (RNAC) competitors?
Other companies in Cartesian Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Inozyme Pharma (NASDAQ:INZY), aTyr Pharma (NASDAQ:ATYR), Neurogene (NASDAQ:NGNE) and Monte Rosa Therapeutics (NASDAQ:GLUE).
What is the forecast, or price target, for Cartesian Therapeutics (RNAC) stock?
Cartesian Therapeutics has a consensus price target of $40.67.
What is the current price for Cartesian Therapeutics (RNAC)?
The stock price for Cartesian Therapeutics (NASDAQ: RNAC) is $10.74 last updated May 20, 2025 at 6:47 PM EDT.
Does Cartesian Therapeutics (RNAC) pay a dividend?
There are no upcoming dividends for Cartesian Therapeutics.
When is Cartesian Therapeutics (NASDAQ:RNAC) reporting earnings?
Cartesian Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is Cartesian Therapeutics (RNAC) going to split?
There is no upcoming split for Cartesian Therapeutics.
What sector and industry does Cartesian Therapeutics (RNAC) operate in?
Cartesian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
